Canadian Prescription Drug Imports
Quick Facts
What Does FDA Authorization of Colorado’s Importation Plan Mean?
Section 804 of the Federal Food, Drug, and Cosmetic Act allows states and certain other sponsors to propose time-limited importation programs. To obtain authorization, a sponsor must show that its program poses no additional risk to public health and safety while producing a significant reduction in covered-product costs for American consumers.
The decision is an important regulatory milestone, but it is not a blanket approval for pharmacies to purchase any medicine from Canada. Colorado must identify eligible products and approved supply-chain participants, submit required information to the FDA and complete product-specific safeguards before commercial importation can begin.
How Will Imported Medicines Be Checked for Safety?
The federal importation rule requires controls intended to preserve the protections of the US pharmaceutical system. An eligible drug generally must correspond to an FDA-approved product apart from its Canadian labeling, and the manufacturer must confirm its authenticity and compliance or supply information needed for qualifying laboratory testing.
Imported products also need labeling that meets US requirements, including prescribing and adverse-event information. Supply-chain records, recall procedures and pharmacovigilance reports are required so regulators can trace products and respond to quality defects, counterfeit medicines or unexpected safety signals.
Which Prescription Drugs Could Be Imported From Canada?
Federal law excludes controlled substances, biological products, infused medicines, intravenously injected drugs, inhaled medicines used during surgery and certain products subject to risk-management restrictions. That means many insulin products, vaccines and other complex biologic therapies cannot enter through this particular importation pathway.
Actual savings will depend on which eligible medicines Colorado selects, whether Canadian suppliers participate and whether testing, relabeling and distribution expenses preserve a meaningful price difference. Patients should continue using their prescribed medicines and established pharmacies unless official state and FDA communications confirm that an imported product has completed every required step.
Frequently Asked Questions
No. FDA authorization allows the program to advance, but product-specific submissions, testing, relabeling and supply-chain arrangements must be completed before eligible medicines can be distributed.
No. Only products meeting the conditions of the FDA-authorized Section 804 program may be imported, and they must correspond to FDA-approved medicines while satisfying US quality and labeling requirements.
Biological products are excluded from the Section 804 pathway. Because many modern insulin products are regulated as biologics, they generally cannot be imported through this program.
References
- STAT. FDA approves Colorado’s plan to import cheaper drugs from Canada. August 5, 2026.
- US Food and Drug Administration. Importation Program under Section 804 of the Federal Food, Drug, and Cosmetic Act.
- Federal Register. Importation of Prescription Drugs, Final Rule. October 1, 2020.
- Colorado Department of Health Care Policy and Financing. Colorado Canadian Prescription Drug Importation Program.